The releases and coverage have been great. With ASCO abstracts set to be released on May 18th, I don't see any reason(other than the stock appearing overbought and the general market risk) to try and time a trade here. I am not sure this is a good thing but, this is the first time I have ever had a substantially large gain in a biotech and I am not really nervous or finding several good reasons to sell some.